MedPath

长春澜江医药科技有限公司

Ownership
-
Established
2019-01-31
Employees
-
Market Cap
-
Website
http://www.ccljyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Paracetamol and Ibuprofen Tablets

Product Name
对乙酰氨基酚布洛芬片
Approval Number
国药准字H20254054
Approval Date
Apr 30, 2025
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20253095
Approval Date
Jan 8, 2025
NMPA

Magnesium Sulfate,Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution

Product Name
硫酸镁钠钾口服用浓溶液
Approval Number
国药准字H20249385
Approval Date
Nov 15, 2024
NMPA

Loratadine Syrup

Product Name
氯雷他定糖浆
Approval Number
国药准字H20244373
Approval Date
Jul 9, 2024
NMPA

Lacosamide Oral Solution

Product Name
拉考沙胺口服溶液
Approval Number
国药准字H20234114
Approval Date
Sep 5, 2023
NMPA

Atomoxetine Hydrochloride Oral Solution

Product Name
盐酸托莫西汀口服溶液
Approval Number
国药准字H20233786
Approval Date
Jun 27, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.